de State Street Acadia Pharmaceuticals ACAD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 230 M | Comprar |
9,076,212
+743,441
| +9% | +USD 16.4 M | 0.01% | 978 |
|
|
2026
Q1 | USD 185 M | Comprar |
8,332,771
+422,038
| +5% | +USD 10.1 M | 0.01% | 983 |
|
|
2025
Q4 | USD 211 M | Comprar |
7,910,733
+655,257
| +9% | +USD 15.7 M | 0.01% | 906 |
|
|
2025
Q3 | USD 155 M | Comprar |
7,255,476
+1,077,432
| +17% | +USD 25.5 M | 0.01% | 1098 |
|
|
2025
Q2 | USD 133 M | Vender |
6,178,044
-815,469
| -12% | -USD 15.2 M | 0.01% | 1152 |
|
|
2025
Q1 | USD 116 M | Comprar |
6,993,513
+2,472,128
| +55% | +USD 44.9 M | ﹤0.01% | 1183 |
|
|
2024
Q4 | USD 83 M | Vender |
4,521,385
-1,452,489
| -24% | -USD 23.4 M | ﹤0.01% | 1452 |
|
|
2024
Q3 | USD 91.9 M | Comprar |
5,973,874
+173,084
| +3% | +USD 2.89 M | ﹤0.01% | 1374 |
|
|
2024
Q2 | USD 94.3 M | Vender |
5,800,790
-200,613
| -3% | -USD 3.24 M | ﹤0.01% | 1300 |
|
|
2024
Q1 | USD 111 M | Vender |
6,001,403
-463,623
| -7% | -USD 11.5 M | 0.01% | 1241 |
|
|
2023
Q4 | USD 202 M | Comprar |
6,465,026
+1,251,295
| +24% | +USD 29.9 M | 0.01% | 836 |
|
|
2023
Q3 | USD 109 M | Vender |
5,213,731
-206,587
| -4% | -USD 5.61 M | 0.01% | 1128 |
|
|
2023
Q2 | USD 130 M | Vender |
5,420,318
-166,543
| -3% | -USD 3.7 M | 0.01% | 1051 |
|
|
2023
Q1 | USD 105 M | Vender |
5,586,861
-2,153,477
| -28% | -USD 41 M | 0.01% | 1154 |
|
|
2022
Q4 | USD 123 M | Comprar |
7,740,338
+961,467
| +14% | +USD 15 M | 0.01% | 1042 |
|
|
2022
Q3 | USD 111 M | Comprar |
6,778,871
+184,921
| +3% | +USD 2.99 M | 0.01% | 1047 |
|
|
2022
Q2 | USD 92.9 M | Comprar |
6,593,950
+1,536,756
| +30% | +USD 28.7 M | 0.01% | 1211 |
|
|
2022
Q1 | USD 122 M | Comprar |
5,057,194
+237,241
| +5% | +USD 5.74 M | 0.01% | 1153 |
|
|
2021
Q4 | USD 112 M | Vender |
4,819,953
-908,370
| -16% | -USD 18.3 M | 0.01% | 1202 |
|
|
2021
Q3 | USD 95.1 M | Comprar |
5,728,323
+1,757,712
| +44% | +USD 33.9 M | 0.01% | 1307 |
|
|
2021
Q2 | USD 96.8 M | Comprar |
3,970,611
+761,973
| +24% | +USD 17.2 M | 0.01% | 1320 |
|
|
2021
Q1 | USD 82.8 M | Comprar |
3,208,638
+598,812
| +23% | +USD 26.4 M | ﹤0.01% | 1377 |
|
|
2020
Q4 | USD 140 M | Vender |
2,609,826
-92,758
| -3% | -USD 4.6 M | 0.01% | 917 |
|
|
2020
Q3 | USD 111 M | Comprar |
2,702,584
+134,840
| +5% | +USD 5.82 M | 0.01% | 909 |
|
|
2020
Q2 | USD 124 M | Vender |
2,567,744
-1,474,552
| -36% | -USD 70.8 M | 0.01% | 837 |
|
|
2020
Q1 | USD 171 M | Comprar |
4,042,296
+38,619
| +1% | +USD 1.59 M | 0.01% | 656 |
|
|
2019
Q4 | USD 171 M | Comprar |
4,003,677
+548,277
| +16% | +USD 23.9 M | 0.01% | 758 |
|
|
2019
Q3 | USD 124 M | Vender |
3,455,400
-1,189,463
| -26% | -USD 36.1 M | 0.01% | 879 |
|
|
2019
Q2 | USD 124 M | Vender |
4,644,863
-220,834
| -5% | -USD 5.64 M | 0.01% | 895 |
|
|
2019
Q1 | USD 131 M | Comprar |
4,865,697
+26,511
| +0.5% | +USD 619 k | 0.01% | 856 |
|
|
2018
Q4 | USD 78.2 M | Vender |
4,839,186
-1,999,013
| -29% | -USD 38.8 M | 0.01% | 1048 |
|
|
2018
Q3 | USD 142 M | Comprar |
6,838,199
+1,011,324
| +17% | +USD 15.9 M | 0.01% | 861 |
|
|
2018
Q2 | USD 89 M | Comprar |
5,826,875
+1,651,126
| +40% | +USD 29.4 M | 0.01% | 1119 |
|
|
2018
Q1 | USD 93.8 M | Comprar |
4,175,749
+852,811
| +26% | +USD 23.6 M | 0.01% | 1042 |
|
|
2017
Q4 | USD 100 M | Comprar |
3,322,938
+82,559
| +3% | +USD 2.64 M | 0.01% | 1009 |
|
|
2017
Q3 | USD 122 M | Vender |
3,240,379
-508,089
| -14% | -USD 16.5 M | 0.01% | 878 |
|
|
2017
Q2 | USD 105 M | Comprar |
3,748,468
+510,670
| +16% | +USD 15.2 M | 0.01% | 943 |
|
|
2017
Q1 | USD 111 M | Vender |
3,237,798
-116,228
| -3% | -USD 4.1 M | 0.01% | 881 |
|
|
2016
Q4 | USD 96.7 M | Comprar |
3,354,026
+246,198
| +8% | +USD 6.51 M | 0.01% | 924 |
|
|
2016
Q3 | USD 98.9 M | Comprar |
3,107,828
+832,503
| +37% | +USD 28.2 M | 0.01% | 881 |
|
|
2016
Q2 | USD 73.9 M | Vender |
2,275,325
-1,089,101
| -32% | -USD 36.4 M | 0.01% | 982 |
|
|
2016
Q1 | USD 94.1 M | Comprar |
3,364,426
+997,205
| +42% | +USD 21.7 M | 0.01% | 865 |
|
|
2015
Q4 | USD 84.4 M | Comprar |
2,367,221
+379,117
| +19% | +USD 13.4 M | 0.01% | 895 |
|
|
2015
Q3 | USD 65.7 M | Comprar |
1,988,104
+63,016
| +3% | +USD 2.62 M | 0.01% | 1015 |
|
|
2015
Q2 | USD 80.6 M | Vender |
1,925,088
-4,522
| -0.2% | -USD 175 k | 0.01% | 971 |
|
|
2015
Q1 | USD 62.9 M | Comprar |
1,929,610
+139,984
| +8% | +USD 4.81 M | 0.01% | 1110 |
|
|
2014
Q4 | USD 56.8 M | Vender |
1,789,626
-97,391
| -5% | -USD 2.76 M | 0.01% | 1158 |
|
|
2014
Q3 | USD 46.7 M | Vender |
1,887,017
-103,408
| -5% | -USD 2.42 M | 0.01% | 1215 |
|
|
2014
Q2 | USD 45 M | Vender |
1,990,425
-33,906
| -2% | -USD 708 k | ﹤0.01% | 1285 |
|
|
2014
Q1 | USD 49.3 M | Comprar |
2,024,331
+90,216
| +5% | +USD 2.28 M | 0.01% | 1205 |
|
|
2013
Q4 | USD 48.3 M | Vender |
1,934,115
-174,765
| -8% | -USD 4.12 M | 0.01% | 1213 |
|
|
2013
Q3 | USD 57.9 M | Comprar |
2,108,880
+140,938
| +7% | +USD 2.95 M | 0.01% | 1074 |
|
|
2013
Q2 | USD 35.7 M | Comprar |
+1,967,942
| Nuevas | +USD 27.1 M | ﹤0.01% | 1295 |
|
Otros fondos que tienen ACAD en su cartera
BBA
Posición de State Street en ACAD: resumen de T2 2026
State Street aumentó su participación en Acadia Pharmaceuticals (ACAD) en 8.9% durante T2 2026, al comprar aproximadamente USD 16.4 M y elevar la posición a 9,076,212 acciones con un valor de USD 230 M. La posición representa 0.01% de la cartera y ocupa el puesto #978.
State Street reportó por primera vez una posición en ACAD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank mantienen una posición en ACAD.
- Al cierre de T2 2026, State Street tenía 9,076,212 acciones de Acadia Pharmaceuticals con un valor de USD 230 M.
- State Street compró 743,441 acciones de Acadia Pharmaceuticals en T2 2026, por un monto estimado de USD 16.4 M.
- Acadia Pharmaceuticals representó 0.01% de la cartera de State Street en T2 2026 y fue su posición número 978.
- State Street reportó por primera vez una posición en Acadia Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank tenían Acadia Pharmaceuticals en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.